Market Overview:
The global OTC anti-infective products market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, rising consumer awareness about self-medication, and growing demand for over-the-counter (OTC) drugs. The global OTC anti-infective products market is segmented on the basis of type into antifungals, antiseptic, and antiparasitics. The antifungal segment is expected to account for the largest share of the global OTC anti-infective products market in 2018. This segment is projected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030 due to increasing incidence of fungal infections across the world. On the basis of application, hospital pharmacies accounted for majority share in 2017 and are projected witness highest growth rate over next few years owing high adoption rate by hospitals as compared other distribution channels such as drug stores, retail stores.
Product Definition:
OTC anti-infective products are used to treat infections that are not severe enough to require a prescription from a doctor. They can be used to treat a variety of different types of infection, including respiratory infections, skin infections, and urinary tract infections. OTC anti-infective products are important because they can help people get relief from their symptoms without having to go see a doctor.
Antifungals:
Antifungals are used to treat fungal infections. Fungal infection includes yeast infections such as thrush, jock itch, ringworm, and athlete's foot. The most common types of fungi that cause infectious diseases are molds (e.g., Aspergillus oryzae), yeasts (e.g., Candida albicans), and mushrooms (e.g., basidiomycetes).
Antiseptic:
Antiseptic is a type of medicine that kills or prevents the growth of microorganisms, mainly because it contains high concentrations of antiseptics. Antiseptics are used to prevent the growth and development of bacteria and other microorganisms that cause infections. Some antiseptic products contain anti-fungal agents as well. The most common types of antiseptics are iodine, alcohols, phenol derivatives (e.g.
Application Insights:
The global OTC anti-infective products market has been segmented on the basis of application into hospital pharmacies, retail stores, e-commerce and drug stores. The retail stores segment is expected to emerge as the fastest growing application over the forecast period owing to factors such as increasing purchasing power of consumers coupled with rising awareness regarding availability of a wide range of OTC drugs.
OTC anti-infective products are widely used in hospitals due to high patient admissions and continuous exposure to various infectious diseases that demand immediate treatment with an antibiotic or antifungal agent. In addition, these pharmaceutical compounds are also sold in supermarkets, drugstores and other shops under different brand names which makes their availability more convenient for patients who have no access to a pharmacy or medical storeroom.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of infectious diseases, rising geriatric population, and high healthcare expenditure. In addition, growing awareness regarding disease prevention and treatment through various programs by government organizations is anticipated to fuel growth over the next eight years.
Asia Pacific is estimated to be fastest-growing regional market from 2018 to 2030 owing with rapid economic development in emerging countries such as India and China along with other South East Asian nations.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the global OTC anti-infective products market. This is because infections are becoming more common and also resistant to antibiotics, thereby necessitating the use of OTC anti-infective products for their treatment.
- Rising awareness about self-medication: There is a rising awareness among consumers about self-medication, which is propelling the demand for OTC anti-infective products. This is because consumers are increasingly preferring to treat themselves without having to go to a doctor or hospital.
- Growing demand from emerging markets: The demand for OTC anti-infective products is growing rapidly in emerging markets such as China and India due to the increasing prevalence of infectious diseases and rising consumer awareness about self-medication in these regions.
- Technological advancements: The advent of new technologies such as nanotechnology has led to the development of novel formulations and delivery systems for OTC anti-infective products, which is aiding their growth prospects globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
OTC Anti-Infective Products Market Research Report
By Type
Antifungals, Antiseptic, Antiparasitics
By Application
Hospital Pharmacies, Drug Stores, Retail Stores, E-Commerce
By Companies
GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche, NanoViricides, Novabay Pharmaceuticals, Optimer Pharmaceuticals, Basilea Pharmaceutica, MerLion Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global OTC Anti-Infective Products Market Report Segments:
The global OTC Anti-Infective Products market is segmented on the basis of:
Types
Antifungals, Antiseptic, Antiparasitics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Drug Stores, Retail Stores, E-Commerce
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Merck
- Pfizer
- Novartis
- Abbott
- Sanofi
- Bristol-Myers Squibb
- Roche
- NanoViricides
- Novabay Pharmaceuticals
- Optimer Pharmaceuticals
- Basilea Pharmaceutica
- MerLion Pharma
Highlights of The OTC Anti-Infective Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antifungals
- Antiseptic
- Antiparasitics
- By Application:
- Hospital Pharmacies
- Drug Stores
- Retail Stores
- E-Commerce
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the OTC Anti-Infective Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OTC anti-infective products are medications that are sold over the counter and do not require a prescription. These products can be used to treat a variety of infections, including colds, flu, and other respiratory infections.
Some of the major players in the otc anti-infective products market are GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche, NanoViricides, Novabay Pharmaceuticals, Optimer Pharmaceuticals, Basilea Pharmaceutica, MerLion Pharma.
The otc anti-infective products market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 OTC Anti-Infective Products Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 OTC Anti-Infective Products Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 OTC Anti-Infective Products Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the OTC Anti-Infective Products Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global OTC Anti-Infective Products Market Size & Forecast, 2020-2028
4.5.1 OTC Anti-Infective Products Market Size and Y-o-Y Growth
4.5.2 OTC Anti-Infective Products Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antifungals
5.2.2 Antiseptic
5.2.3 Antiparasitics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Drug Stores
6.2.3 Retail Stores
6.2.4 E-Commerce
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global OTC Anti-Infective Products Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 OTC Anti-Infective Products Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antifungals
9.6.2 Antiseptic
9.6.3 Antiparasitics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Drug Stores
9.10.3 Retail Stores
9.10.4 E-Commerce
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antifungals
10.6.2 Antiseptic
10.6.3 Antiparasitics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Drug Stores
10.10.3 Retail Stores
10.10.4 E-Commerce
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antifungals
11.6.2 Antiseptic
11.6.3 Antiparasitics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Drug Stores
11.10.3 Retail Stores
11.10.4 E-Commerce
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antifungals
12.6.2 Antiseptic
12.6.3 Antiparasitics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Drug Stores
12.10.3 Retail Stores
12.10.4 E-Commerce
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antifungals
13.6.2 Antiseptic
13.6.3 Antiparasitics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Drug Stores
13.10.3 Retail Stores
13.10.4 E-Commerce
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 OTC Anti-Infective Products Market: Competitive Dashboard
14.2 Global OTC Anti-Infective Products Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Merck
14.3.3 Pfizer
14.3.4 Novartis
14.3.5 Abbott
14.3.6 Sanofi
14.3.7 Bristol-Myers Squibb
14.3.8 Roche
14.3.9 NanoViricides
14.3.10 Novabay Pharmaceuticals
14.3.11 Optimer Pharmaceuticals
14.3.12 Basilea Pharmaceutica
14.3.13 MerLion Pharma
